AGC WAKASA CHEMICALS CO., LTD. – FDA Inspection, Aug 21, 2026

Record Details

This FDA Inspection record concerns AGC WAKASA CHEMICALS CO., LTD., with an inspection on August 21, 2026, issued by the Office of Inspections and Investigations, covering human drugs.

Company: AGC WAKASA CHEMICALS CO., LTD.
Inspection Date: August 21, 2026
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Dorothy P. Kramer

View Company Profile

ID · bebbbecb-c0b1-4b2c-9680-57399d99411b

Inspection Facts

Inspection number: 1332066
FDA center: Human Drugs
Outcome: Form 483 issued, view the record

Other FDA inspections of AGC WAKASA CHEMICALS CO., LTD.

Date	Classification	Office	Project area
November 2, 2023	VAI	Center for Drug Evaluation and Research	Drug Quality Assurance

Other documents for AGC WAKASA CHEMICALS CO., LTD.

FDA Inspection 1223750 - 2023-11-02

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore AGC WAKASA CHEMICALS CO., LTD.

FDA Inspection

AGC WAKASA CHEMICALS CO., LTD.August 21, 2026

AGC WAKASA CHEMICALS CO., LTD. – FDA Inspection, Aug 21, 2026

Record Details

This FDA Inspection record concerns AGC WAKASA CHEMICALS CO., LTD., with an inspection on August 21, 2026, issued by the Office of Inspections and Investigations, covering human drugs.